Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 15 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlersMcVernon, J.; Nolan, T.; Richmond, P.; Reynolds, G.; Nissen, M.; Lambert, S.; Marshall, H.; Papa, T.; Rehm, C.
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2015Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlersBooy, R.; Nolan, T.; Reynolds, G.; Richmond, P.; Nissen, M.; Marshall, H.; Stoney, T.; Van Der Wielen, M.; Kolhe, D.; Miller, J.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2007A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infantsNolan, T.; Lambert, S.; Roberton, D.; Marshall, H.; Richmond, P.; Streeton, C.; Poolman, J.; Boutriau, D.
2011Immunogenicity and safety of an investigational combined haemophilus influenzae Type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccineNolan, T.; Richmond, P.; Marshall, H.; McVernon, J.; Alexander, K.; Mesaros, N.; Aris, E.; Miller, J.; Poolman, J.; Boutriau, D.
2011Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of ageBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2006A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 yearsMarshall, H.; Nolan, T.; Roberton, D.; Richmond, P.; Lambert, S.; Jacquet, J.; Schuerman, L.
2005Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old childrenRoberton, D.; Marshall, H.; Nolan, T.; Sokal, E.; Diez-Domingo, J.; Flodmark, C.; Rombo, L.; Lewald, G.; de la Flor, J.; Casanaovas, J.; Verdaguer, J.; Mares, J.; Van Esso, D.; Dieussaert, I.; Stoffel, M.